Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023.

Wai Yuen Tong Medicine Holdings Limited (SEHK:897) commences share repurchases on April 2, 2024 under the program mandated by the shareholders in the Annual General Meeting held on August 22, 2023. As per the mandate, the company is authorized to repurchase up to 117,110,288 shares, representing 10% of the issued share capital. The repurchases will result in an increase in the earnings per share.

Repurchases made pursuant to the New Repurchase Mandate would be funded from the Company?s available cash flow or working capital facilities legally available for the purpose in accordance with the Company?s memorandum of association, the Bye-Laws, the applicable laws and regulations of Bermuda and other applicable laws. The authority shall expire at the earliest of the next Annual General Meeting, the date on which the next Annual General Meeting is required to be held or the date on which the authority is varied or revoked in a General Meeting. As at August 22, 2023, the company has 1,171,102,888 shares in issue.